Cargando…
Tackling Thyroid Cancer in Europe—The Challenges and Opportunities
Thyroid cancer (TC) is the most common malignancy of the endocrine system that affects the thyroid gland. It is usually treatable and, in most cases, curable. The central issues are how to improve knowledge on TC, to accurately identify cases at an early stage that can benefit from effective interve...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498891/ https://www.ncbi.nlm.nih.gov/pubmed/36141235 http://dx.doi.org/10.3390/healthcare10091621 |
_version_ | 1784794873020284928 |
---|---|
author | Horgan, Denis Führer-Sakel, Dagmar Soares, Paula Alvarez, Clara V. Fugazzola, Laura Netea-Maier, Romana T. Jarzab, Barbara Kozaric, Marta Bartes, Beate Schuster-Bruce, James Dal Maso, Luigino Schlumberger, Martin Pacini, Furio |
author_facet | Horgan, Denis Führer-Sakel, Dagmar Soares, Paula Alvarez, Clara V. Fugazzola, Laura Netea-Maier, Romana T. Jarzab, Barbara Kozaric, Marta Bartes, Beate Schuster-Bruce, James Dal Maso, Luigino Schlumberger, Martin Pacini, Furio |
author_sort | Horgan, Denis |
collection | PubMed |
description | Thyroid cancer (TC) is the most common malignancy of the endocrine system that affects the thyroid gland. It is usually treatable and, in most cases, curable. The central issues are how to improve knowledge on TC, to accurately identify cases at an early stage that can benefit from effective intervention, optimise therapy, and reduce the risk of overdiagnosis and unnecessary treatment. Questions remain about management, about treating all patients in referral centres, and about which treatment should be proposed to any individual patient and how this can be optimised. The European Alliance for Personalised Medicine (EAPM) hosted an expert panel discussion to elucidate some of the challenges, and to identify possible steps towards effective responses at the EU and member state level, particularly in the context of the opportunities in the European Union’s evolving initiatives—notably its Beating Cancer Plan, its Cancer Mission, and its research funding programmes. Recommendations emerging from the panel focus on improved infrastructure and funding, and on promoting multi-stakeholder collaboration between national and European initiatives to complement, support, and mutually reinforce efforts to improve patient care. |
format | Online Article Text |
id | pubmed-9498891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94988912022-09-23 Tackling Thyroid Cancer in Europe—The Challenges and Opportunities Horgan, Denis Führer-Sakel, Dagmar Soares, Paula Alvarez, Clara V. Fugazzola, Laura Netea-Maier, Romana T. Jarzab, Barbara Kozaric, Marta Bartes, Beate Schuster-Bruce, James Dal Maso, Luigino Schlumberger, Martin Pacini, Furio Healthcare (Basel) Perspective Thyroid cancer (TC) is the most common malignancy of the endocrine system that affects the thyroid gland. It is usually treatable and, in most cases, curable. The central issues are how to improve knowledge on TC, to accurately identify cases at an early stage that can benefit from effective intervention, optimise therapy, and reduce the risk of overdiagnosis and unnecessary treatment. Questions remain about management, about treating all patients in referral centres, and about which treatment should be proposed to any individual patient and how this can be optimised. The European Alliance for Personalised Medicine (EAPM) hosted an expert panel discussion to elucidate some of the challenges, and to identify possible steps towards effective responses at the EU and member state level, particularly in the context of the opportunities in the European Union’s evolving initiatives—notably its Beating Cancer Plan, its Cancer Mission, and its research funding programmes. Recommendations emerging from the panel focus on improved infrastructure and funding, and on promoting multi-stakeholder collaboration between national and European initiatives to complement, support, and mutually reinforce efforts to improve patient care. MDPI 2022-08-25 /pmc/articles/PMC9498891/ /pubmed/36141235 http://dx.doi.org/10.3390/healthcare10091621 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Perspective Horgan, Denis Führer-Sakel, Dagmar Soares, Paula Alvarez, Clara V. Fugazzola, Laura Netea-Maier, Romana T. Jarzab, Barbara Kozaric, Marta Bartes, Beate Schuster-Bruce, James Dal Maso, Luigino Schlumberger, Martin Pacini, Furio Tackling Thyroid Cancer in Europe—The Challenges and Opportunities |
title | Tackling Thyroid Cancer in Europe—The Challenges and Opportunities |
title_full | Tackling Thyroid Cancer in Europe—The Challenges and Opportunities |
title_fullStr | Tackling Thyroid Cancer in Europe—The Challenges and Opportunities |
title_full_unstemmed | Tackling Thyroid Cancer in Europe—The Challenges and Opportunities |
title_short | Tackling Thyroid Cancer in Europe—The Challenges and Opportunities |
title_sort | tackling thyroid cancer in europe—the challenges and opportunities |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498891/ https://www.ncbi.nlm.nih.gov/pubmed/36141235 http://dx.doi.org/10.3390/healthcare10091621 |
work_keys_str_mv | AT horgandenis tacklingthyroidcancerineuropethechallengesandopportunities AT fuhrersakeldagmar tacklingthyroidcancerineuropethechallengesandopportunities AT soarespaula tacklingthyroidcancerineuropethechallengesandopportunities AT alvarezclarav tacklingthyroidcancerineuropethechallengesandopportunities AT fugazzolalaura tacklingthyroidcancerineuropethechallengesandopportunities AT neteamaierromanat tacklingthyroidcancerineuropethechallengesandopportunities AT jarzabbarbara tacklingthyroidcancerineuropethechallengesandopportunities AT kozaricmarta tacklingthyroidcancerineuropethechallengesandopportunities AT bartesbeate tacklingthyroidcancerineuropethechallengesandopportunities AT schusterbrucejames tacklingthyroidcancerineuropethechallengesandopportunities AT dalmasoluigino tacklingthyroidcancerineuropethechallengesandopportunities AT schlumbergermartin tacklingthyroidcancerineuropethechallengesandopportunities AT pacinifurio tacklingthyroidcancerineuropethechallengesandopportunities |